Quality Control News and Research

RSS

Waters exhibits the SYNAPT G2 system at the 18th International Mass Spectrometry Conference in Europe

Waters Corporation (NYSE: WAT) today exhibited for the first time in Europe the Waters((R)) SYNAPT(TM) G2 a system offering scientists greater power, versatility and speed at the 18(th) International Mass Spectrometry Conference (IMSC). Rounding out its display of mass spectrometry (MS) and UltraPerformance Liquid Chromatography (UPLC((R)))/MS systems at IMSC will be Waters Xevo(TM) family of tandem quadrupole and time-of-flight mass spectrometers noted for their ease-of-use and versatility.

27 Aug 2009

More than 22,000 Americans expected to be diagnosed with a malignant brain tumor in 2009

It is expected that more than 22,000 Americans will be diagnosed with a malignant brain tumor in 2009. Senator Ted Kennedy's death from a brain cancer draws attention to a rare, but often fatal type disease. While the risk of developing brain cancer is relatively low, it is important to heed the warning signs and receive an accurate diagnosis.

27 Aug 2009

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Guardian Technologies International, Inc. (OTCBB: GDTI) today announced that its Software Quality Assurance Team has completed all unit, component, integration, and systems tests of Signature Mapping TBDx™ (TBDx™) in preparation for September clinical trials in South Africa.

26 Aug 2009

Interactive Intelligence's CIC communications software suite deployed at WRB Communications

WRB Communications, a medical information call center services company, has deployed the Interactive Intelligence (Nasdaq: ININ) all-in-one IP communications software suite, Customer Interaction Center® (CIC).

26 Aug 2009

Synexus acquires three more clinical trial centres in Poland

Synexus’ expansion in Central and Eastern Europe has been boosted with the acquisition of three more clinical trial centres in Poland.

From AES - Accelerated Enrollment Solutions 24 Aug 2009

Varian Medical Systems to equip a new proton therapy center in Sweden

Varian Medical Systems today announced it has been selected to equip a new proton therapy center in Sweden. In a ceremony conducted by Swedish authorities yesterday following a public tender, Varian was named to supply an estimated $60 million in products for Skandionkliniken, a new national proton therapy center owned by a consortium of seven of Sweden's counties.

20 Aug 2009

Supplemental Manufacturing and Ingredients forges manufacturing agreement with HealthSport's subsidiary, InnoZen

InnoZen, Inc., a wholly owned subsidiary of HealthSport, Inc. (OTC Bulletin Board: HSPO) announced today that it has entered into a manufacturing agreement with Supplemental Manufacturing and Ingredients, LLC ("SMI"), a cGMP certified manufacturer based in Tempe, Arizona. As part of the Agreement, SMI has committed to purchasing $1,000,000 worth of HealthSport common stock.

20 Aug 2009

MicroDynamics to introduce the MicroQC inspection microscope at Quality Expo

MicroDynamics will be introducing the MicroQC inspection microscope at Quality Expo. The MicroQC is a highly versatile, lightweight instrument that is extremely accurate with proven repeatable results.

19 Aug 2009

Efforts to create treatment guidelines are often complicated

The development of treatment guidelines for illnesses such as diabetes is a complicated process.

19 Aug 2009

New software programs improve the cancer biomarker identification process

caCORRECT and omniBioMarker programs earn silver-level compatibility certification from NIH/National Cancer Institute's cancer Bioinformatics Grid

19 Aug 2009

First batch of cancer vaccine from Cancer Vaccine Collaborative goes into trial

The first batch of NY-ESO-1 recombinant protein produced in a facility supported entirely by non-profit entities has successfully cleared regulatory review and has entered clinical testing. The clinical trials are part of the Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd. (LICR).

13 Aug 2009

At VA hospital, a rogue cancer unit

The New York Times reports that a "rogue cancer unit" at a veteran's hospital in Philadelphia "operated with virtually no outside scrutiny and botched 92 of 116 [prostate] cancer treatments over a span of more than six years - and then kept quiet about it, according to interviews with investigators, government officials and public records."

22 Jun 2009

Antiretroviral therapy earlier yields better clinical outcomes

A clinical trial has demonstrated that HIV-infected adults in a resource-limited setting are more likely to survive if they start antiretroviral therapy (ART) before their immune systems are severely compromised.

9 Jun 2009

Advances in cystic fibrosis genetic testing

San Juan Capistrano, CA and Chantilly, VA –Three reports describing advances in cystic fibrosis genetic testing appear in the May 2009 issue of The Journal of Molecular Diagnostics .

27 Apr 2009

Malaria diagnostic tests differ in performance

The largest-ever independent, laboratory-based evaluation of rapid diagnostic tests (RDTs) for malaria has shown that some tests on the market perform exceptionally well in tropical temperatures and can detect even low parasite densities in blood samples, while other tests can detect parasites only at high densities.

26 Apr 2009

Multivitamins have no impact on risk of cancer or heart disease in postmenopausal women

The largest study of its kind concludes that long-term multivitamin use has no impact on the risk of common cancers, cardiovascular disease or overall mortality in postmenopausal women.

12 Apr 2009

Blood test that predicts seriousness of a head injury gains momentum

A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.

31 Mar 2009

Court of Appeal for Saskatchewan allows Merck's appeal

Merck Frosst Canada Ltd. has learned that the Court of Appeal for Saskatchewan has issued a decision allowing Merck's appeal and quashing an order of the Court of Queen's Bench that had certified a class proceeding on behalf of Canadian residents of all provinces except Quebec who purchased or ingested VIOXX.

30 Mar 2009

Preliminary health insurer survey results indicate some patients want to know physician's race when selecting provider

According to preliminary results of an automated phone survey by Highmark, some health plan members would like the race of physicians included in the insurer's physician directory, the Pittsburgh Tribune Review reports.

23 Mar 2009

New aspirin recommendation can help prevent heart attacks and strokes among many adults

A new recommendation from the U.S. Preventive Services Task Force (USPSTF) underscores the value of regular aspirin use in preventing heart attacks and strokes among many adults, the head of Partnership for Prevention said today.

16 Mar 2009

Quality Control News and Research

Waters exhibits the SYNAPT G2 system at the 18th International Mass Spectrometry Conference in Europe

More than 22,000 Americans expected to be diagnosed with a malignant brain tumor in 2009

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Interactive Intelligence's CIC communications software suite deployed at WRB Communications

Synexus acquires three more clinical trial centres in Poland

Varian Medical Systems to equip a new proton therapy center in Sweden

Supplemental Manufacturing and Ingredients forges manufacturing agreement with HealthSport's subsidiary, InnoZen

MicroDynamics to introduce the MicroQC inspection microscope at Quality Expo

Efforts to create treatment guidelines are often complicated

New software programs improve the cancer biomarker identification process

First batch of cancer vaccine from Cancer Vaccine Collaborative goes into trial

At VA hospital, a rogue cancer unit

Antiretroviral therapy earlier yields better clinical outcomes

Advances in cystic fibrosis genetic testing

Malaria diagnostic tests differ in performance

Multivitamins have no impact on risk of cancer or heart disease in postmenopausal women

Blood test that predicts seriousness of a head injury gains momentum

Court of Appeal for Saskatchewan allows Merck's appeal

Preliminary health insurer survey results indicate some patients want to know physician's race when selecting provider

New aspirin recommendation can help prevent heart attacks and strokes among many adults

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News